AU2015900184A0 - Improved formulation of pentosan polysulfate sodium and sodium hyaluronate - Google Patents

Improved formulation of pentosan polysulfate sodium and sodium hyaluronate

Info

Publication number
AU2015900184A0
AU2015900184A0 AU2015900184A AU2015900184A AU2015900184A0 AU 2015900184 A0 AU2015900184 A0 AU 2015900184A0 AU 2015900184 A AU2015900184 A AU 2015900184A AU 2015900184 A AU2015900184 A AU 2015900184A AU 2015900184 A0 AU2015900184 A0 AU 2015900184A0
Authority
AU
Australia
Prior art keywords
sodium
pentosan polysulfate
improved formulation
hyaluronate
sodium hyaluronate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2015900184A
Inventor
Angelis Vasili
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RANDLAB AUSTRALIA Pty Ltd
Original Assignee
RANDLAB AUSTRALIA Pty Ltd
Filing date
Publication date
Application filed by RANDLAB AUSTRALIA Pty Ltd filed Critical RANDLAB AUSTRALIA Pty Ltd
Publication of AU2015900184A0 publication Critical patent/AU2015900184A0/en
Abandoned legal-status Critical Current

Links

AU2015900184A 2015-01-22 Improved formulation of pentosan polysulfate sodium and sodium hyaluronate Abandoned AU2015900184A0 (en)

Publications (1)

Publication Number Publication Date
AU2015900184A0 true AU2015900184A0 (en) 2015-02-05

Family

ID=

Similar Documents

Publication Publication Date Title
EP3110427A4 (en) Compositions of pentosan polysulfate salts for oral administration and methods of use
EP3397260A4 (en) Methods and compositions relating to chondrisomes from blood products
EP3234062A4 (en) Compositions and methods of improving hydraulic fracture network
EP3139920A4 (en) Anti-viral compounds, pharmaceutical compositions, and methods of use thereof
IL255818A (en) Pentosan polysulfate sodium for the treatment of sickle cell disease
IL251545A0 (en) Compositions comprising sulfated polysaccharides and uses thereof
HK1250657A1 (en) High elasticity hyaluronan compositions and methods of use thereof
EP3386927A4 (en) Polymer compositions and methods of use
EP3101015A4 (en) Heterocyclic sulfonamide derivative and medicine comprising same
EP3319609A4 (en) Compositions and methods of use of antibacterial drug combinations
PT3590971T (en) Pentosan polysulfate, pharmaceutical composition and anticoagulant
EP3389674A4 (en) Cellular glycosaminoglycan compositions and methods of making and using
EP3242769A4 (en) Preparation and application of pb-free nanosolder
EP3367820A4 (en) Preparation of modified cellulose and its derivatives
HK1222572A1 (en) Pharmaceutical compositions comprising collagen and sodium hyaluronate
EP3091983A4 (en) Products and pharmaceutical compositions
EP3717559A4 (en) Encapsulation of modifiers in depolymerized products
EP3398971A4 (en) Sulfated heparin oligosaccharide and preparation method and application thereof
EP3730521A4 (en) Pentosan polysulfate and medicine containing pentosan polysulfate
EP3311176A4 (en) Role of citrullination in diagnosing diseases
EP3145922A4 (en) Dipicolylamine derivatives and their pharmaceutical uses
EP3273985A4 (en) Il-1ra based compositions and treatments
EP3120852A4 (en) Prophylactic and/or therapeutic agent for immune diseases
EP3258917A4 (en) Methods to reduce toxicities and to improve bioavailabilities of nanodrugs
AU2015900184A0 (en) Improved formulation of pentosan polysulfate sodium and sodium hyaluronate